SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Credit Suisse Maintains Outperform on Acceleron Pharma, Raises Price Target to $134

Credit Suisse analyst Martin Auster maintains Acceleron Pharma (NASDAQ:XLRN) with a Outperform and raises the price target from $123 to $134.

Benzinga · -
Credit Suisse analyst Martin Auster maintains Acceleron Pharma (NASDAQ: XLRN) with a Outperform and raises the price target from $123 to $134.